Literature DB >> 19139041

Feedback inhibition of action potential discharge by endogenous adenosine enhancement of the medium afterhyperpolarization.

Ming Ruan1, Colin H Brown.   

Abstract

Phasic activity in supraoptic nucleus vasopressin neurones is characterized by alternating periods of activity (bursts) and silence. During bursts, activation of a medium afterhyperpolarization induces spike frequency adaptation. Antagonism of A1 adenosine receptors within the supraoptic nucleus decreases spike frequency adaptation and prolongs phasic bursts in vivo, indicating that endogenous adenosine contributes to spike frequency adaptation. Here we used sharp electrode intracellular recordings from supraoptic nucleus neurones in hypothalamic explants to show that endogenous adenosine increases medium afterhyperpolarization amplitude to enhance spike frequency adaptation during phasic bursts. Superfusion of the A1 receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT, 10 microM) increased intraburst firing rate of phasic neurones (by 2.0 +/- 0.7 spikes s(-1), P = 0.03) and burst duration (by 141 +/- 113 s, P = 0.03). The CPT-induced increase in intraburst firing rate developed over the first few seconds of firing and persisted thereafter. In a separate series of experiments, CPT reduced the amplitude of the medium afterhyperpolarization evoked by a 1 s 20 Hz spike train (by 0.8 +/- 0.3 mV, P < 0.001) in supraoptic nucleus neurones; this inhibition was not prevented by 3 mM CsCl (0.8 +/- 0.1 mV decrease, P < 0.01) to block the afterdepolarization (which overlaps temporally with the medium afterhyperpolarization). In the presence of apamin to block the medium afterhyperpolarization, CPT did not alter afterdepolarization amplitude. Taken together, these data show that endogenous adenosine enhances medium afterhyperpolarization amplitude to contribute to spike frequency adaptation in phasic supraoptic nucleus neurones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139041      PMCID: PMC2673774          DOI: 10.1113/jphysiol.2008.167239

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  53 in total

1.  Excitatory role of the hyperpolarization-activated inward current in phasic and tonic firing of rat supraoptic neurons.

Authors:  M Ghamari-Langroudi; C W Bourque
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Endogenous activation of supraoptic nucleus kappa-opioid receptors terminates spontaneous phasic bursts in rat magnocellular neurosecretory cells.

Authors:  Colin H Brown; Gareth Leng; Mike Ludwig; Charles W Bourque
Journal:  J Neurophysiol       Date:  2006-02-22       Impact factor: 2.714

3.  Adenosine-induced presynaptic inhibition of IPSCs and EPSCs in rat hypothalamic supraoptic nucleus neurones.

Authors:  S H Oliet; D A Poulain
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

4.  Vasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro.

Authors:  M L Hermes; J M Ruijter; A Klop; R M Buijs; L P Renaud
Journal:  J Neurophysiol       Date:  2000-02       Impact factor: 2.714

5.  Adenosine inhibits voltage-dependent Ca2+ currents in rat dissociated supraoptic neurones via A1 receptors.

Authors:  J Noguchi; H Yamashita
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

6.  Vasopressin regulation of noradrenaline release within the supraoptic nucleus.

Authors:  M Ludwig; T Onaka; K Yagi
Journal:  J Neuroendocrinol       Date:  2000-06       Impact factor: 3.627

Review 7.  Somatodendritic dynorphin release: orchestrating activity patterns of vasopressin neurons.

Authors:  C H Brown; V Scott; M Ludwig; G Leng; C W Bourque
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

8.  Activity-dependent feedback modulation of spike patterning of supraoptic nucleus neurons by endogenous adenosine.

Authors:  P M Bull; C H Brown; J A Russell; M Ludwig
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07       Impact factor: 3.619

9.  Vasopressin preferentially depresses excitatory over inhibitory synaptic transmission in the rat supraoptic nucleus in vitro.

Authors:  S B Kombian; D Mouginot; M Hirasawa; Q J Pittman
Journal:  J Neuroendocrinol       Date:  2000-04       Impact factor: 3.627

Review 10.  Multi-factorial somato-dendritic regulation of phasic spike discharge in vasopressin neurons.

Authors:  Colin H Brown; Ming Ruan; Victoria Scott; Vicky A Tobin; Mike Ludwig
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  6 in total

1.  Apamin increases post-spike excitability of supraoptic nucleus neurons in anaesthetized morphine-naïve rats and morphine-dependent rats: consequences for morphine withdrawal excitation.

Authors:  Philip M Bull; John A Russell; Victoria Scott; Colin H Brown
Journal:  Exp Brain Res       Date:  2011-06-14       Impact factor: 1.972

2.  Isoflurane preconditioning and postconditioning in rat hippocampal neurons.

Authors:  Richard J McMurtrey; Zhiyi Zuo
Journal:  Brain Res       Date:  2010-08-13       Impact factor: 3.252

Review 3.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

4.  Dehydration-induced modulation of kappa-opioid inhibition of vasopressin neurone activity.

Authors:  Victoria Scott; Valerie R Bishop; Gareth Leng; Colin H Brown
Journal:  J Physiol       Date:  2009-10-12       Impact factor: 5.182

Review 5.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

6.  Information coding in vasopressin neurons--the role of asynchronous bistable burst firing.

Authors:  D J MacGregor; T F Clayton; G Leng
Journal:  Biosystems       Date:  2013-03-14       Impact factor: 1.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.